Cercar
01/09/2025
Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study
Martín-Aguilar, L, Blanco-Sanromán, N, Appiani, FE, Caballero-Avila, M, Vidal, N, Martínez-Martínez, L, Querol, L, Vidal-Jordana, A. Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/04/2025
Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
Osuna-Gómez, R, Zamora, C, Novelli, S, Garcia-Pallarols, F, Rodriguez, Y, Domingo, A, Canet, M, Olivera, P, Mulet, M, Cantó, E, Valcarcel, D, Sanchez-Gonzalez, B, Vidal, S. Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 206(4)DOI:10.1111/bjh.19779. PMID:39327831. IF:3.800(Q1/3D).
01/01/2025
Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
Arguello-Tomas, M, Mozas, P, Albiol, N, López-Esteban, M, Sierra, J, Nomdedéu, J, Martinez-Laperche, C, Moga, E, Piñeyroa, JA, Delgado, J, Osorio, S, Moreno, C. Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy. CANCER. 2025; 131(1)DOI:10.1002/cncr.35552. PMID:39264834. IF:5.100(Q1/3D).
04/04/2023
A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.
Laghi L, Román E, Lan Q, Nieto JC, Canalda-Baltrons A, Poca M, Sánchez-Rodríguez MB, Clària J, Alvarado E, Cuyàs B, Sánchez E, Vidal S, Guarner C, Escorsell À, Manichanh C, Soriano G. A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.. Hepatology Communications. 2023; 7(4)DOI:10.1097/HC9.0000000000000072. PMID:37026745. IF:5.600(Q1/2D).